Attached files

file filename
EX-31.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3101.htm
EX-10.2 - CONFIRMATION OF LEASE TERM - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex1002.htm
EX-32.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3202.htm
EX-31.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3102.htm
EXCEL - IDEA: XBRL DOCUMENT - Brooklyn ImmunoTherapeutics, Inc.Financial_Report.xls
10-Q - 10-Q - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-063011.htm
Exhibit 32.1
 
Certification pursuant to Rule 13a-14(b) / Section 1350
 
In connection with the Quarterly Report of NTN Buzztime, Inc. (the “Registrant”) on Form 10-Q for the period ended June 30, 2011, I, Michael Bush, President and Chief Executive Officer, do hereby certify that:
 
(1)
the Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2011, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
   
Dated: August 12, 2011
/s/ Michael Bush
 
Michael Bush
 
President and Chief Executive Officer
 
NTN Buzztime, Inc.